Lumosa Therapeutics Co., Ltd. (TPEX: 6535)
Taiwan
· Delayed Price · Currency is TWD
237.00
+1.00 (0.42%)
Jan 22, 2025, 1:30 PM CST
Lumosa Therapeutics Market Cap
Lumosa Therapeutics has a market cap or net worth of 39.86 billion as of January 21, 2025. Its market cap has increased by 261.69% in one year.
Market Cap
39.86B
Enterprise Value
39.33B
Revenue
37.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
233.50
Market Cap Chart
Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 39.86B, an increase of 828.07%. That is a compound annual growth rate of 26.35%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
PharmaEssentia | 235.68B |
Caliway Biopharmaceuticals | 98.05B |
Bora Pharmaceuticals Co., LTD. | 80.81B |
Lotus Pharmaceutical | 69.14B |
Oneness Biotech | 37.34B |
Polaris Group | 32.38B |
Center Laboratories | 29.18B |
Pegavision | 29.02B |